(NP (NP (NP Contribution/NN) (PP of/IN (NP (NP-COOD (NP NF-kappa/NN B/NN) and/CC (NP Sp1/NN)) binding/NN motifs/NNS)) (PP to/TO (NP (NP the/DT replicative/JJ capacity/NN) (PP of/IN (NP human/JJ immunodeficiency/NN virus/NN type/NN 1/CD)))) :/:) (S (NP-SBJ-26 (NP distinct/JJ patterns/NNS) (PP of/IN (NP viral/JJ growth/NN))) (VP are/VBP (VP determined/VBN (NP *-26/-NONE-) (PP by/IN (NP-LGS T-cell/NN types/NNS)))) ./.))
(S (S-ADV (NP-SBJ */-NONE-) (VP Starting/VBG (PP with/IN (NP (NP a/DT replication-incompetent/JJ molecular/JJ clone/NN) (PP of/IN (NP human/JJ immunodeficiency/NN virus/NN type/NN 1/CD)) ,/, (VP lacking/VBG (NP (NP all/PDT the/DT (NP-COOD (NP NF-kappa/NN B/NN) and/CC (NP Sp1/NN)) binding/NN sites/NNS) (ADJP present/JJ (PP in/IN (NP the/DT native/JJ (NP (NP long/JJ terminal/JJ repeat/NN) (PRN -LRB-/-LRB- (NP LTR/NN) -RRB-/-RRB-))))))))))) ,/, (NP-SBJ-27 (NP proviruses/NNS) (VP containing/VBG (NP (NP reconstructed/VBN LTRs/NNS) (PP with/IN (NP (NP-COOD (NP individual/JJ (NP *RNR*-100/-NONE-)) or/CC (NP (NP combinations/NNS) (PP of/IN (NP *RNR*-100/-NONE-)))) (NP-100 (NP-COOD (NP NF-kappa/NN B/NN) and/CC (NP Sp1/NN)) elements/NNS)))))) (VP were/VBD (VP-COOD (VP generated/VBN (NP *-27/-NONE-)) and/CC (VP evaluated/VBN (NP *-27/-NONE-) (PP for/IN (NP their/PRP$ capacity/NN (S (NP-SBJ */-NONE-) (VP to/TO (VP produce/VB (NP virus/NN progeny/NN) (PP-TMP following/VBG (NP transfection-cocultivation/NN)))))))))) ./.)
(S (NP-SBJ (NP Virus/NN stocks/NNS) (VP obtained/VBN (NP */-NONE-) (PP from/IN (NP these/DT experiments/NNS)))) (VP exhibited/VBD (NP (NP a/DT continuum/NN) (PP of/IN (NP replicative/JJ capacities/NNS)) (PP in/IN (NP different/JJ human/JJ T-cell/NN types/NNS))) (PP depending/VBG (PP on/IN (SBAR (WHNP-30 which/WDT element/NN -LRB-/-LRB- s/NNS -RRB-/-RRB-) (S (NP-SBJ *T*-30/-NONE-) (VP was/VBD (ADJP-PRD present/JJ (PP in/IN (NP the/DT LTR/NN))))))))) ./.)
(S (PP For/IN (NP example/NN)) ,/, (PP in/IN (NP (NP experiments/NNS) (VP involving/VBG (NP (NP proviral/JJ clones/NNS) (PP with/IN (NP (NP LTRs/NNS) (VP containing/VBG (NP-COOD (NP (QP one/CD or/CC two/CD) NF-kappa/NN B/NN elements/NNS) -LRB-/-LRB- and/CC (NP no/DT Sp1/NN binding/NN sites/NNS) -RRB-/-RRB-)))))))) ,/, (NP-SBJ-31 (NP a/DT hierarchy/NN) (PP of/IN (NP (NP cellular/JJ permissivity/NN) (PP to/TO (NP virus/NN replication/NN)))) (PRN -LRB-/-LRB- (S (NP-SBJ peripheral/JJ blood/NN lymphocytes/NNS) (VP =/JJ (NP-PRD (NP MT4/NN) (ADJP (ADJP greater/JJR) (PP than/IN (NP (NP H9/NN) (ADJP (ADJP greater/JJR) (PP than/IN (NP (NP CEM/NN) (ADJP (ADJP greater/JJR) (PP than/IN (NP Jurkat/NN)))))))))))) -RRB-/-RRB-)) (VP was/VBD (VP observed/VBN (NP *-31/-NONE-))) ./.)
(SINV (PP-PRD-TPC-32 Of/IN (NP note/NN)) (VP was/VBD (PP-PRD *T*-32/-NONE-)) (NP-SBJ (NP the/DT associated/VBN emergence/NN) (PP of/IN (NP second-site/JJ LTR/NN revertants/NNS)) (SBAR (WHNP-33 which/WDT) (S (NP-SBJ *T*-33/-NONE-) (VP involved/VBD (NP (NP an/DT alteration/NN) (PP of/IN (NP the/DT TATA/NN box/NN))))))) ./.)
(S (NP-SBJ These/DT results/NNS) (VP suggest/VBP (SBAR that/IN (S (NP-SBJ-101 the/DT human/JJ immunodeficiency/NN virus/NN type/NN 1/CD LTR/NN) (VP-COOD (VP possesses/VBZ (NP (NP functional/JJ redundancy/NN) (SBAR (WHNP-34 which/WDT) (S (NP-SBJ *T*-34/-NONE-) (VP ensures/VBZ (NP (NP virus/NN replication/NN) (PP in/IN (NP different/JJ T-cell/NN types/NNS)))))))) and/CC (VP is/VBZ (ADJP-PRD capable/JJ (PP of/IN (S (NP-SBJ *-101/-NONE-) (VP changing/VBG))) (PP depending/VBG (PP on/IN (NP (NP the/DT particular/JJ combination/NN) (PP of/IN (NP (NP transcriptional/JJ factors/NNS) (ADJP present/JJ)))))))))))) ./.)
